Abstract:BACKGROUND:Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks effective therapeutic targets. Sperm-associated antigen 5 (SPAG5) is a mitotic spindle-associated protein that is involved in various biological processes in cervical cancer and bladder urothelial carcinoma. However, the role of SPAG5 in TNBC remains undefined.METHODS:The expression of SPAG5 was examined in TNBC patients via quantitative real-time polymerase chain reaction (qRT-PCR), western blotting, and immunohistochemistry (IHC). The biological functions of SPAG5 in TNBC and the underlying mechanisms were investigated in vitro and in vivo.RESULTS:SPAG5 expression was significantly upregulated in TNBC tissues compared with that in paired adjacent noncancerous tissues (ANTs). High SPAG5 expression was associated with increased lymph node metastasis and high risk of local recurrence. SPAG5 protein expression was significantly associated with poor disease-free survival in TNBC. Gene set enrichment analysis of TNBC data from The Cancer Genome Atlas (TCGA) indicated that high SPAG5 expression was significantly associated with cell cycle and the ATR-BRCA pathway. Functional assays demonstrated that SPAG5 expression promoted tumor growth in vitro and in vivo. In addition, SPAG5-silenced cells were more sensitive to the PARP inhibitor (PARPi) olaparib. Mechanistically, SPAG5 interacted with c-MYC binding protein (MYCBP), thereby increasing MYCBP protein levels and leading to increased c-MYC transcriptional activity, which promoted the expression of the c-MYC target genes: CDC20, CDC25C, BRCA1, BRCA2, and RAD51.Knockdown of MYCBP or c-MYC abolished the SPAG5-induced cell-cycle progression and cell proliferation of TNBC.CONCLUSIONS:Collectively, our results indict that SPAG5 is an efficient prognostic factor in TNBC, and that SPAG5 knockdown increases the sensitivity of TNBC to the PARPi olaparib. SPAG5 promotes tumor growth and DNA repair by increasing c-MYC transcriptional activity via interaction with MYCBP. The SPAG5/MYCBP/c-MYC axis may represent a potential therapeutic target for TNBC treatment.

High Expression of SPAG5 Sustains the Malignant Growth and Invasion of Breast Cancer Cells Through the Activation of Wnt/β‐catenin Signalling

SPAG5 Upregulation Contributes to Enhanced C-Myc Transcriptional Activity Via Interaction with C-Myc Binding Protein in Triple-Negative Breast Cancer.

High Expression of UNC5B Enhances Tumor Proliferation, Increases Metastasis, and Worsens Prognosis in Breast Cancer.

Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers

SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway

Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation

Data from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

A comprehensive pan-cancer analysis revealing SPAG6 as a novel diagnostic, prognostic and immunological biomarker in tumor

[Biological role of SPAG5 in the malignant proliferation of gastric cancer cells]

P53 Suppression is Essential for Oncogenic SPAG5 Upregulation in Lung Adenocarcinoma.

Sperm Associated Antigen 4 Promotes SREBP1-mediated De Novo Lipogenesis Via Interaction with Lamin A/C and Contributes to Tumor Progression in Hepatocellular Carcinoma

SPAG5 As a Novel Biomarker and Potential Therapeutic Target Via Regulating AKT Pathway in Multiple Myeloma.

Additional File 8: of SPAG5 Upregulation Contributes to Enhanced C-Myc Transcriptional Activity Via Interaction with C-Myc Binding Protein in Triple-Negative Breast Cancer

Secreted Phosphoprotein 1 As a Potential Prognostic and Immunotherapy Biomarker in Multiple Human Cancers

HOXB5 Promotes the Progression of Breast Cancer Through Wnt/beta-Catenin Pathway.

A novel tumor suppressor SPINK5 targets Wnt/β‐catenin signaling pathway in esophageal cancer

Upregulated SPAG6 promotes acute myeloid leukemia progression through MYO1D that regulates the EGFR family expression

Sperm-Associated Antigen 5 Knockout Reduces Doxorubicin and Docetaxel Resistance in Triple-Negative Breast Cancer MDA-MB-231 and BT549 Cells

Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness

Protein arginine methyltransferase 5 (PRMT5) activates WNT/β‐catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3

USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition Via Wnt/β-Catenin Pathway